Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
Stock Information for Sernova Corp.
Loading
Please wait while we load your information from QuoteMedia.